Skip to main content
ATOSSA THERAPEUTICS, INC. logo

ATOSSA THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · ATOS ISIN · US04962H5063 US Manufacturing
Open in API
Filings indexed 622 across all filing types
Latest filing 2010-12-16 Capital/Financing Update
Country US United States of America
Listing US ATOS

About ATOSSA THERAPEUTICS, INC.

https://atossatherapeutics.com/

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovative medicines for areas of significant unmet medical need, with a primary focus on oncology. The company is dedicated to addressing the full continuum of breast cancer care. Its lead program is centered on (Z)-endoxifen, a proprietary and potent selective estrogen receptor modulator (SERM). Atossa is advancing (Z)-endoxifen through clinical development for multiple breast cancer indications, including metastatic disease, aiming to provide a therapeutic with a potentially improved efficacy and tolerability profile.

Recent filings

Filing Released Lang Actions
Capital/Financing Update 2010
Capital/Financing Update Classification · 100% confidence The document is a Form S-1/A, which is an amendment to a registration statement filed with the SEC under the Securities Act of 1933. It is related to an initial public offering (IPO) of securities by Atossa Genetics Inc. The document includes detailed information about the offering, the company, risk factors, use of proceeds, management discussion and analysis, and other disclosures typical of a registration statement prospectus. This type of filing is a capital markets document used to register securities for sale to the public, not a financial report, earnings release, or management report. It is not an announcement or a brief summary but a comprehensive registration statement. Therefore, the appropriate classification is Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities such as IPO registration statements.
2010-12-16 English
Capital/Financing Update 2010
Capital/Financing Update Classification · 100% confidence The document is a Form S-1/A Registration Statement Amendment No. 1 filed with the SEC by Atossa Genetics Inc. It is a registration statement under the Securities Act of 1933 for an initial public offering (IPO) of units consisting of common stock and warrants. The document includes detailed information about the offering, risk factors, use of proceeds, capitalization, dilution, management discussion and analysis, business description, management, executive compensation, principal stockholders, and legal matters. This type of filing is a capital raising document used to register securities for public sale and is not a financial report, earnings release, or other types of filings listed. The document is clearly a capital/financing update related to the company's IPO process and securities registration. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed offering information, consistent with a capital raising filing rather than a simple announcement or regulatory filing.
2010-11-23 English
S-1
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, dated September 30, 2010, for Atossa Genetics Inc. It is a registration statement under the Securities Act of 1933 for an initial public offering (IPO) of units consisting of common stock and warrants. The document includes detailed information about the offering, the company, risk factors, use of proceeds, management, and financial data. This type of filing is a registration statement for securities offering, which is a capital raising activity. Therefore, it fits the category of Capital/Financing Update filings, which cover company fundraising and financing activities.
2010-10-01 English
Regulatory Filings 2010
Regulatory Filings
2010-09-28 English
Regulatory Filings 2010
Regulatory Filings Classification · 100% confidence The document is a letter from Atossa Genetics, Inc. to the SEC requesting the withdrawal of a Registration Statement on Form S-1. It explicitly states the withdrawal of a registration statement related to a public offering and references SEC rules about fees and future filings. The document is short (2209 characters) and is a formal withdrawal request, not a financial report or detailed filing. This fits the category of a Regulatory Filing (RNS) as it is a regulatory communication about the status of a filing rather than a report or announcement of financial results or capital changes.
2010-07-27 English
Regulatory Filings 2010
Regulatory Filings
2010-06-24 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.